Atrial Fibrillation Management and Outcomes

Atrial fibrillation is an irregular heart rhythm in which the upper chambers of the heart quiver rather than contract properly, allowing blood to pool and form clots that can travel to the brain and cause stroke. Researchers and clinicians study how best to reduce that risk through anticoagulant drugs — comparing older agents like warfarin against newer alternatives such as rivaroxaban and dabigatran — and through procedures like catheter ablation, which uses heat or cold energy to disrupt the faulty electrical signals driving the arrhythmia. A central challenge is risk stratification: identifying which patients face enough danger from stroke or bleeding to justify aggressive treatment, and which can be managed more conservatively. Active debates center on the long-term durability of ablation versus medication, how to tailor anticoagulation to individual patient profiles, and how guidelines should incorporate emerging evidence from large clinical trials.

Works

152,645

Total citations

2,346,652

Keywords

Atrial FibrillationAnticoagulant TherapyCatheter AblationStroke PreventionRisk StratificationGuidelines